• The monthly packaging world
• /
• s.235
• /
• pp.105-109
• /
• 2012

식품의약품안전청은 안전상비의약품의 약국 외 판매를 도입하는 내용의 "약사법"이 개정(법률 제11421호, 2012. 5. 14.공포)됨에 따라 일반소비자가 안전상비의약품의 효능 효과, 용법 용량 등의 정보를 쉽고 정확하게 이해하여 안전하게 사용할 수 있도록 안전상비의약품의 기재요령을 정하고 기존 고시의 문제점을 보완하고자 의약품 표시 등에 관한 규정 일부개정고시(안)를 행정예고했다. 또한 식약청은 "의약품 표시 등에 관한 규정"이 이미 행정예고(식품의약품안전청 공고 제2012-120호, 2012. 6. 13) 되었으나 안전상비의약품의 용기나 포장에 허가 또는 신고사항 일부를 요약 기재할 수 있도록 "약사법 시행규칙"이 개정 추진됨에 따라 본 고시를 다시 행정예고한다고 밝혔다. 주요 내용에 대해 살펴본다.

• Korean Journal of Clinical Pharmacy
• /
• v.31 no.3
• /
• pp.180-187
• /
• 2021

Objective: We investigated arthralgia and myalgia associated with the use of oral bisphosphonate (BP) by conducting a survey of patient. Methods: The pharmacists conducted a survey between 1 Oct 2019 and 30 Sep 2020 among patients who were dispensed BP in community pharmacies to assess their demographic and medical characteristics, and their experiences with, and process for pain. Logistic regression analyses were performed to find the risk factors associated with the pain, and the odds ratios (OR) and 95% confidence intervals (CI) were determined. Results: A total of 160 patients who used BP participated in the survey (74 [46.3%] used risedronate; 61 [38.1%] used alendronate; 23 [14.4%] used ibandronate), and 20 (12.5%) of them experienced pain. Significant statistical differences of the characteristics between patients who experienced pain or not were observed regarding menopause, and parity. Compared with women who had one or two parity, women who had more than three parity were associated with the decreased risk of pain (OR, 0.24; 95% CI, 0.04-0.98). Moreover, steady exercise was associated with the decreased risk of pain compared to less exercise (OR, 0.37; 95% CI, 0.14-0.98). Conclusion: Our findings suggest that the risk of pain in BP-treated patients might be different regarding the different ingredients of BP, and dosing frequency. This survey highlights a need for a further safety research to understand the factors influencing the pain associated with the BP treatment.

• 대한한약신문
• /
• s.116
• /
• pp.1-12
• /
• 2006

2006년도 제3차 회장단 협의회/정부, 약사법.의료법 전면개정안 국회 제출/"한약재 품질관리 강화된다"/생산단계서 의약품으로 구별 관리해야/치료효과 보장.암시하는 의료광고 형사처벌/의료단체 행정소송 이어 연말정산 '헌법소원' 제기/난치성질환 치료에 '한의학' 적극 활용/한의학연, 사상의학 본격 연구/의료비 자료제출 거부기관 세무조사 경고/"한약, 간기능 악화 요인 없다"/의료기관 공진단 취급 '주의 요망'/한의원, 자체 제조한 안약.연고 등 판매불가/"의료비 소득제출 유언비어 살포시 고발조치"/"연말정산 미제출 병의원 세무조사 없다"/복지부, 요양기관 녹색인증제 폐지/소득.학력 높을수록 약국 서비스에 불만족/PD수첩 방영된 한의사 3명 징계 결정/부정합 판정 한약재 취급 업소 행정처분/개원한의사 전문의 면허시험 자격인정 연구/지부탐방-지부장에게 듣는다/칼럼-고쟁이와 자궁병/애증 이야기/명칭이 비슷하여 감별하기 어려운 한약재/성약과 패륜아/우리 약초를 찾아서-치자나무/한방과 항문질환/노인들 아스피린을 상용하면/전호, 오용에 대한 소고

• The Journal of the Convergence on Culture Technology
• /
• v.8 no.4
• /
• pp.303-311
• /
• 2022

Recently the telemedicine platform firms which have been temporarily permitted since COVID-19 outbreak have increasingly provided online prescription drugs delivery, causing concerns among incumbent providers of medicine, some of whom began to take aggressive actions again them. In this study, using game theoretic market entry - deterrence model, we show that although the incumbent medicine provider can effectively deter entry by the telemedicine platform firms by its preemptive action, accommodation could be a optimal action when telemedicine platform firms already have penetrated the market with their being permitted to do business due to the COVID-19. However, for the incumbent to cooperate for the successful change in the retail market for medicines, policies like placing a ceiling on the maximum number of taking prescriptions by the pharmacists a day in the telemedince platform network, providing favorable exposure of community pharmacists on the telemedicine platform user interface, and allowing community pharmacies to participate as shareholders of the telemedicine platform firms in its initial public opening of capital, are suggested.

• Journal of Korean society of Dental Hygiene
• /
• v.21 no.4
• /
• pp.403-412
• /
• 2021

Objectives: The objectives of this study were to assess oral health knowledge and behavior levels of community pharmacists as a step toward projecting them to play the role of oral health partners and to confirm pharmacists' willingness to participate in oral health education programs. Methods: t-test and one-way analysis of variance were performed to analyze the data, and correlation analysis was also performed. Results: The mean score for pharmacists' oral health knowledge was 7.29 out of 10. Of the 12 questions asked, the correct answer rate was highest for the question about the effect of smoking cessation on periodontal disease prevention; conversely, the correct answer rate was lowest for the question about the effect of taking medication for gingival infections on periodontal disease prevention. The mean score for pharmacists' oral health behavior was 2.97 out of 4 points. Of all oral health behaviors, brushing twice a day was the most practiced, whereas immediately visiting a dentist in case of an oral health issue was the least practiced. Pharmacists' oral health knowledge and behavior levels showed a weak positive correlation with their intention to participate in oral health education programs. Conclusions: Oral health education programs are necessary to improve community pharmacists' oral health knowledge and behavior.

• Korean Journal of Clinical Pharmacy
• /
• v.19 no.2
• /
• pp.159-166
• /
• 2009

The purpose of this study was to evaluate the attitude and knowledge of community pharmacists to spontaneous adverse drug reaction (ADR) reporting. A survey was conducted in 103 community pharmacists in Seoul and Kyung-Gi Province from September to October, 2009. Almost half (53, 51.5%) and three-fourths (79, 76.7%) of respondents knew they could participate in ADR reporting in the Regional Pharmacovigilance Center (RPC) or Korean Food and Drug Administration (KFDA). However, only three of them have reported an ADR to the RPC and none of them have reported to KFDA. A majority of the respondents (96, 93.2%) felt that ADR reporting was a professional obligation for pharmacists. The purpose of an ADR reporting was incorrectly identified by most pharmacists. ADR reporting was encouraged if the reaction was serious and a new product. The most frequently mentioned barriers to reporting were: uncertainty concerning the causal relationship (86.3%) and not knowing how to report an ADR (83.2%). Only 19 (18.4%) respondents had received education on how to report ADR. Education was the most recognized method of improving ADR reporting. This study showed the knowledge of ADR reporting among community pharmacists is inadequate. Education and training should be reinforced in order to improve ADR reporting by community pharmacists.

• The KIPS Transactions:PartC
• /
• v.10C no.3
• /
• pp.281-286
• /
• 2003

Nowadays, a patient's private medical data which is exposed to the outside world has a severe effect on not only the patient's private life but also his/her social activities and environment. So, it is important to securely protect the patient's private medical data from the illegal manipulation. This paper studies the method to store the electronic prescription information in an IC card. For that, an access control for users, such as a doctor, a nurse, a medical institute member, a pharmacy, a pharmacist, or a patient, is proposed to access the data stored in an IC card. The certificate is issued using the Crypto API of a certificate management model supported by Windows 2000. The public/private key is created by the Cryptographic Service Provider program, and the electronic prescription is signed using the digital signature. The proposed system, therefore, can improve the quality of medical services by securing the safety and integrity of the electronic prescription, stored in an IC card.

• Korean Journal of Clinical Pharmacy
• /
• v.25 no.2
• /
• pp.94-101
• /
• 2015

Background: In order to achieve the goals of community pharmacy practice, its legal, labour-related, and economic barriers need to be identified. This study examined pharmacists' perceptions of constraints on providing optimal pharmacy services in order to identify underlying factors and analyse the associations between barriers and pharmaceutical services in community pharmacies. Methods: A survey targeting pharmacy owners was conducted from May to June 2012 using a structured questionnaire including nine pharmaceutical service items. According to the service provision level, we classified pharmacists as inactive (fewer than 5 items among the listed 9 service items) and active providers (5 or more items). Principal component analysis was used to group significant factors for barriers into four thematic components. Associations between the participants' demographics and pharmacy characteristics and the services provided were explored by logistic regression analyses. Results: Participants were 402 pharmacists. Over 60% provided disease management services for hypertension, diabetes, and hyperlipidaemia. Variables that affected pharmaceutical services included the lack of separate areas for patient counselling (OR: 2.12, 95% CI: 1.18-3.80), and clinical knowledge and information-related barriers (OR: 0.59, 95% CI: 0.36-0.97). Conclusion: Strategies for improving clinical knowledge and providing expeditious information are necessary in order to improve community pharmacy services.

• Korean Journal of Clinical Pharmacy
• /
• v.27 no.4
• /
• pp.228-237
• /
• 2017

Objective: We conducted a survey to understand the current state of pharmacy services and pharmacists' thoughts in the future of the community pharmacy setting. Methods: A questionnaire was distributed to 229 pharmacists and gathered from 95 respondents. Results: We asked to pharmacists about what the ideal pharmacy duty should be in the next 10 years at the community pharmacy setting in Korea. For this question, the respondents said drug counselling (19.4%), dispensing (13.8%), long-term care of chronic disease and healthcare education (12.8%), and OTC counselling (11.5%). When asked about how much time they were spending doing certain tasks in the pharmacy, the main tasks were dispensing (23.5%), counselling (17.1%), prescription review (10.1%), and OTC counselling (5.5%). When asked about what the most important duty of a pharmacist was, medication counselling (45.4%) was the most important task that they identified and the reasons for not being able to fulfill this role properly was time shortage (78.9%) followed by the lack of counselling spaces, up-to-date knowledges, and focus on financial gains over patient counselling. Conclusion: Korean pharmacists are mainly focusing on dispensing in their daily work. Their basic responsibilities can be easily mechanized over the next few years, but the social expectations of disease-prevention and public health promotion both in current and future can not be replaced by such mechanical measures. Therefore, pharmaceutical services in Korea should be developed in more diverse and professional ways.

• Korean Journal of Clinical Pharmacy
• /
• v.16 no.1
• /
• pp.9-13
• /
• 2006

Patient counseling is emerging as one of the most important roles of community pharmacists because the information on the standard labeling for the prescription drug is not sufficient to ensure the correct use of the drug. However, excessive workload of the community pharmacists in Korea discourages the provision of the effective patient counseling. The use of auxiliary label may be an efficient tool to help patients correctly use the prescription drug in this situation. As a preliminary study to encourage the use of auxiliary label, we have performed a survey analysis of familiarity and willingness of community pharmacists to use the auxiliary label. About three quarters of the participating community pharmacists have heard of the auxiliary label, however, there was not a single pharmacist who uses the label. Furthermore, only one fifth of the participating pharmacists were willing to use the label if they have to purchase. Therefore, it is recommended that governmental and non-profit organizations such as Korean Pharmaceutical Association educate community pharmacists regarding usefulness of the auxiliary label with focus on enhancing patient compliance and constrainment of healthcare expense.